BRM HY24 NPAT up 39% but tax tailwind masks weaker 31% PBT lift

What changed

Revenue (investment income) rose 29.1% to $19.7m and profit before tax rose 31.4% to $17.8m. NPAT grew a faster 39.3% to $17.0m, but that gap reflects tax rather than operations: the tax charge fell from $1.3m to $0.8m, compressing the effective rate from 9.87% to 4.45%. Operating cash inflow lifted 67.8% to $9.9m, and closing cash nearly tripled to $10.5m from $3.6m. The balance sheet expanded materially, with total assets up 18.3% to $212.3m and equity up 18.5% to $211.1m against liabilities of just $1.3m. The declared interim dividend rose 6.6% to 1.45 cents per share.

What matters

• PBT is the cleaner read, not NPAT. The 7.9 percentage point gap between NPAT growth (+39.3%) and PBT growth (+31.4%) is driven entirely by a lower effective tax rate. For underlying progress, PBT of $17.8m versus $13.6m is the figure to anchor on.
• Balance-sheet direction is unambiguously stronger. Equity rose $33.0m to $211.1m, cash nearly tripled, and liabilities are negligible at $1.3m. ROE improved to 8.1% from 6.9%, consistent with a listed investment vehicle whose earnings power is compounding off a larger NAV base.
• Income-generation intensity has declined versus FY23. Annualised HY24 revenue of $39.3m sits roughly 9.8% below FY23's $43.6m, so even a strong HY24 against a weak HY23 does not yet restore the prior-year run rate.

Expectations

No formal target, guidance, or forward-work disclosure was provided. The FY23 shape was heavily second-half weighted — HY23 delivered only 35.0% of FY23 revenue and 31.9% of FY23 NPAT — so a straight doubling of HY24 understates any second-half replication. On that pattern, HY24's $19.7m and $17.0m could comfortably re-approach FY23 outcomes, but this hinges entirely on market-driven investment returns in 2H, which the release does not attempt to forecast. The interim dividend of 1.45 cents is the current announcement component only, not a full-period total.

Quality of result

Operating cash flow of $9.9m is a genuine improvement and broadly corroborates the earnings lift, and receivables are effectively nil (about one day), so there is no working-capital distortion to strip out. However, for an investment-company structure, a large share of reported profit typically reflects mark-to-market movements on investments rather than cash dividend income — the $2.0m dividend income line is a small fraction of $17.8m PBT, which points to unrealised gains doing most of the work. The NPAT boost from a sub-5% effective tax rate should also not be assumed to repeat. Treating PBT as the operating benchmark and recognising the market-dependent nature of the gains, the result is of moderate durability rather than high quality.

Unresolved

• What portion of the $19.7m revenue is realised dividend/interest income versus unrealised gains on investments, and how sensitive is that to market levels post balance date?
• Why did the effective tax rate collapse to 4.45%, and is that a timing item, an imputation credit utilisation effect, or structural?
• Capex, gross borrowings, net debt, and NTA per share are not disclosed, so free cash flow, leverage and P/NTA cannot be computed.
• The release provides no forward work, target, or management commentary on 2H shape, despite FY23's heavy second-half skew.

This briefing cannot assess portfolio composition, underlying investment performance attribution, or whether the reported gains have held since balance date.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.